Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Onyx Biotec IPO: Things Smart Investors Need to Know Before Investing

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Overview of the Company

Onyx Biotec Limited, incorporated in May 2005, specializes in manufacturing sterile water for injections and operates as a pharmaceutical contract manufacturer. With a broad range of dry powder injections and syrups, the company caters to both Indian and international clients. Onyx Biotec’s two manufacturing units, located in Solan, Himachal Pradesh, offer robust production capabilities, delivering high-quality pharmaceutical solutions.

Core Business and Market Position

The company’s core business revolves around supplying sterile injections and providing contract manufacturing services for leading pharmaceutical brands such as Hetero Healthcare and Sun Pharmaceuticals. Boasting certifications like ISO 9001:2015 and ISO 14001:2015, Onyx Biotec has solidified its position as a reputable name in the pharmaceutical sector. Its impressive client list of over 100 firms highlights its market reach and reliability.

Onyx Biotec IPO Details and Objectives

The Onyx Biotec IPO will be a fresh issue of 4.81 million shares aggregating to ₹29.34 crores.

IPO Details Table:

Detail

Information

IPO Open Date

November 13, 2024

IPO Close Date

November 18, 2024

Listing Exchange

NSE SME

Price Band

₹58 to ₹61 per share

Lot Size

2000 Shares

Issue Size

4,810,000 shares (₹29.34 Cr)

Purpose of the IPO:

  • Upgrading existing Unit I for large volume parentals.
  • Establishing a high-speed packaging line for Dry Powder Injections.
  • Repayment of loans.
  • General corporate purposes.

 

Timeline of Onyx Biotec IPO

Event

Date

IPO Open Date

November 13, 2024

IPO Close Date

November 18, 2024

Basis of Allotment

November 19, 2024

Initiation of Refunds

November 20, 2024

Credit to Demat

November 20, 2024

Listing Date

November 21, 2024

Pricing & Lot Size of Onyx Biotec IPO

  • Price Band for the IPO: ₹58 to ₹61 per share.
  • Minimum Lot Size and Application Details:
    • Minimum investment of 2000 shares (₹122,000).
    • HNI minimum investment: 2 lots (4000 shares, ₹244,000).

How to Apply for the Onyx Biotec IPO

Online Application Process:

  • Visit Bajaj Broking trading app or website.
  • Log in to your demat account.
  • Go to the IPO section and select "Onyx Biotec IPO."
  • Choose the lot size and enter the bidding price within the specified band.
  • Complete the application by authorizing the UPI mandate for payment or using the ASBA (Application Supported by Blocked Amount) process through your bank.

Financial Health and Performance

Key Financial Metrics:

  • Revenue growth of 35.99% for the financial year ending March 31, 2024, compared to the previous fiscal year.
  • Profit After Tax (PAT) surged by 64.35% between FY 2024 and FY 2023, indicating robust profit expansion.
  • Total assets as of May 31, 2024, stood at ₹7,476.57 lakhs, reflecting increased operational scale.
  • Net worth rose to ₹2,618.64 lakhs as of May 31, 2024, up from ₹2,487.87 lakhs in March 2024.
  • Reserves and surplus increased to ₹1,286.42 lakhs in May 2024, from ₹1,155.65 lakhs in March 2024.

Recent Performance and Growth Prospects:

  • Expanded client base to over 100 Indian and multinational pharmaceutical firms.
  • Strategic upgrades to manufacturing facilities aimed at boosting efficiency and capacity.
  • Strong focus on market expansion in domestic and international markets, enhancing competitive edge and client reach.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO:

  • Competitive and fragmented market landscape.
  • Dependence on regulatory compliance.
  • Fluctuating financial performance.

Opportunities and Growth Potential:

  • Growing demand for sterile pharmaceuticals.
  • Potential for market expansion.
  • Strong customer base with reputed clients.

Key Performance Indicator (KPI)

KPI

Values

ROE

4.99%

ROCE

3.71%

Debt/Equity

1.21

P/BV

3.1

PAT Margin (%)

12.42%

Onyx Biotec IPO Registrar & Lead Managers

Role

Name

Contact Details

Registrar

Mas Services Limited

Phone: (011) 2610 4142
Email: ipo@masserv.com
Website: maserv.com

Lead Manager(s)

Horizon Management Private Limited

-

Company Address of Onyx Biotec Ltd

Onyx Biotec Limited
Bir Plassi, Near Sainimajraropar,
Nalagarh Road, District Solan – 174101,
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: onyxbiotec.com

Conclusion

The Onyx Biotec IPO presents an opportunity for investors to be part of a growing pharmaceutical player known for its quality and established market reach. While the IPO carries risks typical of the industry, the growth potential and strong client network offer promising returns for informed investors.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Frequently Asked Questions

Who is the CEO of Onyx Biotec Ltd?

Answer Field

Sanjay Jain is the CEO, leading strategic and operational growth initiatives

When will the Onyx Biotec IPO open for subscription?

Answer Field

The IPO opens on November 13, 2024, and closes on November 18, 2024.

What is the price band for the Onyx Biotec IPO, and how was it determined?

Answer Field

The price band is ₹58 to ₹61 per share, based on demand and market valuation.

What are the key risks and rewards of investing in the Onyx Biotec IPO?

Answer Field

Key risks include market competition and regulatory challenges. Rewards stem from growth potential and a strong client network.

What documents should I review before investing in the Onyx Biotec IPO?

Answer Field

Review the RHP, financial statements, and company history for informed decision-making.

What are the lock-up period details for the Onyx Biotec IPO?

Answer Field

Specific lock-up details are not available.

Will Onyx Biotec IPO pay dividends?

Answer Field

Dividend distribution depends on future profitability and board decisions.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text